Cargando…
Development of a vaccine to prevent Japanese encephalitis: a brief review
Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840557/ https://www.ncbi.nlm.nih.gov/pubmed/20360904 |
_version_ | 1782178993769807872 |
---|---|
author | Wiwanitkit, Viroj |
author_facet | Wiwanitkit, Viroj |
author_sort | Wiwanitkit, Viroj |
collection | PubMed |
description | Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed. |
format | Text |
id | pubmed-2840557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-28405572010-04-01 Development of a vaccine to prevent Japanese encephalitis: a brief review Wiwanitkit, Viroj Int J Gen Med Review Japanese encephalitis (ICD 10: A83.0) is an important specific viral encephalitis caused by the Japanese encephalitis virus, a virus of the Flavivirus group. Millions of people, especially those in endemic areas of developing countries in Asia, are at high risk from this infection. Therefore proper management to deal with this virus is essential. There is no specific treatment for Japanese encephalitis virus. Supportive and symptomatic treatments are usually used, which emphasize the importance of prevention in this specific neurological disorder. Vector control or vaccination can be used to prevent the disease. Because the existing Japanese encephalitis vaccine poses some undesirable problems, a new vaccine is needed. The process of developing a new vaccine is briefly discussed. Dove Medical Press 2009-12-29 /pmc/articles/PMC2840557/ /pubmed/20360904 Text en © 2009 Wiwanitkit, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Wiwanitkit, Viroj Development of a vaccine to prevent Japanese encephalitis: a brief review |
title | Development of a vaccine to prevent Japanese encephalitis: a brief review |
title_full | Development of a vaccine to prevent Japanese encephalitis: a brief review |
title_fullStr | Development of a vaccine to prevent Japanese encephalitis: a brief review |
title_full_unstemmed | Development of a vaccine to prevent Japanese encephalitis: a brief review |
title_short | Development of a vaccine to prevent Japanese encephalitis: a brief review |
title_sort | development of a vaccine to prevent japanese encephalitis: a brief review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840557/ https://www.ncbi.nlm.nih.gov/pubmed/20360904 |
work_keys_str_mv | AT wiwanitkitviroj developmentofavaccinetopreventjapaneseencephalitisabriefreview |